对血清铁蛋白低于500μg/L的输血依赖型地中海贫血患者进行铁螯合治疗的整体方法。 - Suppr

A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 μg/L.

作者信息

Scaramellini Natalia, Consonni Dario, Cassinerio Elena, Arighi Carola, Marcon Alessia, Graziadei Giovanna, Cappellini Maria Domenica, Motta Irene

机构信息

Università degli Studi di Milano, Milan, Italy.

Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Am J Hematol. 2020 Sep;95(9):E230-E232. doi: 10.1002/ajh.25860. Epub 2020 Jun 15.

DOI:10.1002/ajh.25860

PMID:32390147

Abstract

摘要

相似文献

A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 μg/L.

Am J Hematol. 2020 Sep;95(9):E230-E232. doi: 10.1002/ajh.25860. Epub 2020 Jun 15.

Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM).

Eur J Haematol. 2019 Feb;102(2):123-130. doi: 10.1111/ejh.13180. Epub 2018 Dec 9.

Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.

Eur J Haematol. 2017 Mar;98(3):280-288. doi: 10.1111/ejh.12830. Epub 2017 Jan 13.

Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients.

Am J Hematol. 2018 Oct;93(10):E338-E340. doi: 10.1002/ajh.25222. Epub 2018 Aug 14.

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.

Haematologica. 2024 Jul 1;109(7):2271-2276. doi: 10.3324/haematol.2023.283610.

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.

Br J Haematol. 2015 Jan;168(2):284-90. doi: 10.1111/bjh.13119. Epub 2014 Sep 12.

Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload.

Infect Disord Drug Targets. 2015;15(2):98-105. doi: 10.2174/1871526515666150724111721.

Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes.

Eur J Haematol. 2018 Sep;101(3):272-282. doi: 10.1111/ejh.13111. Epub 2018 Jul 27.

Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.

Prog Clin Biol Res. 1979;34:351-9.

Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et al.

Br J Haematol. 2017 Mar;176(6):989-990. doi: 10.1111/bjh.14018. Epub 2016 Mar 11.

引用本文的文献

Iron Chelation Therapy.

Adv Exp Med Biol. 2025;1480:361-370. doi: 10.1007/978-3-031-92033-2_23.

Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring.

Sci Rep. 2021 Jun 15;11(1):12581. doi: 10.1038/s41598-021-91983-w.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 μg/L.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献